Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Moreno

Showing results (311-320 of 548) with videos related to

Pageof 55
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2023
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid TumorsMaria Vieito, Victor Moreno, Anna Spreafico, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2013
Bacterial natural transformation by highly fragmented and damaged DNASøren Overballe-Petersen, Klaus Harms, Ludovic A A Orlando, et al.
Nucleic Acids Research|February 17, 2022
GCAT|Panel, a comprehensive structural variant haplotype map of the Iberian population from high-coverage whole-genome sequencingJordi Valls-Margarit, Iván Galván-Femenía, Daniel Matías-Sánchez, et al.
International Journal of Cancer|August 14, 2023
Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation studyAndrei-Emil Constantinescu, Caroline J Bull, Nicholas Jones, et al.
Cancer Chemotherapy and Pharmacology|March 17, 2022
First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancersEnriqueta Felip, Victor Moreno, Daniel Morgensztern, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2021
Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 AntibodyJames J Harding, Victor Moreno, Yung-Jue Bang, et al.
International Journal of Molecular Sciences|October 26, 2024
Metagenomic Study Reveals Phage-Bacterial Interactome Dynamics in Gut and Oral Microbiota in Pancreatic DiseasesLaura Vilà-Quintana, Esther Fort, Laura Pardo, et al.
Occupational and Environmental Medicine|June 18, 2016
Night shift work and stomach cancer risk in the MCC-Spain studyGeorgina Gyarmati, Michelle C Turner, Gemma Castaño-Vinyals, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2007
Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signatureItziar Salaverria, Andreas Zettl, Sílvia Beà, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2011
A combined strategy of SAGE and quantitative PCR Provides a 13-gene signature that predicts preoperative chemoradiotherapy response and outcome in rectal cancerEnrique Casado, Victor Moreno García, Jose Javier Sánchez, et al.
Pageof 55

Showing results (311-320 of 548) with videos related to

Sort By:
Pageof 55
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2023
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid TumorsMaria Vieito, Victor Moreno, Anna Spreafico, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2013
Bacterial natural transformation by highly fragmented and damaged DNASøren Overballe-Petersen, Klaus Harms, Ludovic A A Orlando, et al.
Nucleic Acids Research|February 17, 2022
GCAT|Panel, a comprehensive structural variant haplotype map of the Iberian population from high-coverage whole-genome sequencingJordi Valls-Margarit, Iván Galván-Femenía, Daniel Matías-Sánchez, et al.
International Journal of Cancer|August 14, 2023
Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation studyAndrei-Emil Constantinescu, Caroline J Bull, Nicholas Jones, et al.
Cancer Chemotherapy and Pharmacology|March 17, 2022
First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancersEnriqueta Felip, Victor Moreno, Daniel Morgensztern, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2021
Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 AntibodyJames J Harding, Victor Moreno, Yung-Jue Bang, et al.
International Journal of Molecular Sciences|October 26, 2024
Metagenomic Study Reveals Phage-Bacterial Interactome Dynamics in Gut and Oral Microbiota in Pancreatic DiseasesLaura Vilà-Quintana, Esther Fort, Laura Pardo, et al.
Occupational and Environmental Medicine|June 18, 2016
Night shift work and stomach cancer risk in the MCC-Spain studyGeorgina Gyarmati, Michelle C Turner, Gemma Castaño-Vinyals, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2007
Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signatureItziar Salaverria, Andreas Zettl, Sílvia Beà, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2011
A combined strategy of SAGE and quantitative PCR Provides a 13-gene signature that predicts preoperative chemoradiotherapy response and outcome in rectal cancerEnrique Casado, Victor Moreno García, Jose Javier Sánchez, et al.
Pageof 55